about
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cellsPharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerRoles and regulations of the ETS transcription factor ELF4/MEFThe role of prostate tumor overexpressed 1 in cancer progressionA novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progeniesGene expression pathways of high grade localized prostate cancer.Activation of c-MET induces a stem-like phenotype in human prostate cancerCancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.DNA repair: the culprit for tumor-initiating cell survival?Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cellsFrequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ΔNp63αAnimal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheresPharmacogenomics and cancer stem cells: a changing landscape?Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling.New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancerCryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression.Why are epididymal tumours so rare?Genotypes of cancer stem cells characterized by epithelial-to-mesenchymal transition and proliferation related functions.DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer MetastasisEndogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.Searching for prostate cancer stem cells: markers and methods.Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer.Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.Long-term recovery of irradiated prostate cancer increases cancer stem cells.GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol.Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer.Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state.Krüppel-like factor 2 suppresses human gastric tumorigenesis through inhibiting PTEN/AKT signaling.Could ALDH2*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?
P2860
Q24302022-EADB4EDB-9AF2-4D1E-BAB6-4F72864A7E88Q24632276-BC4A0F3A-5605-41F3-BC08-E48E6E474020Q28072925-322BF086-783C-4A87-9579-854C4927C30DQ28079350-19146501-37A6-4BD7-A1A7-818DF45A8209Q30504566-B9DEFDCB-B297-46E5-AA41-5A40C5525817Q31049380-62689567-69C5-4164-A947-228943A313A9Q33832517-AAE80512-2418-48FE-83E7-DA68E2FA5F17Q34081431-261B2F49-5D2D-48B9-86F4-89BED537B7E9Q34143362-0CEA4F5C-9661-43FD-967C-3B43FB675732Q34804212-B3C6E8A3-9F3B-4F5B-8439-6807D98EFB75Q35233174-46A9FE08-96DC-4E3E-A54A-C92AD5953996Q35287094-1C7536E8-E602-4562-BEEF-C9F6516FB763Q35674175-C253BBD1-B723-4A1F-AD3C-5487B5079B97Q35746535-17499F3F-65F7-44D9-920F-EC8AA831BAB3Q35886877-9DC88AD6-922A-493D-AA02-4A96E84E39C3Q36157197-616EE9DD-D58B-4A0C-9E3F-A482C188D442Q36196598-1C65E5F1-915A-455D-A422-30D8E931698FQ36251549-2D96275B-9556-4069-8781-AE430FC14CD3Q36407872-81517C34-220D-42FB-BADB-6F8948CB0105Q36546480-7364E26D-96F7-4100-8B9A-AE497D786BA2Q36603335-1F7826EE-A059-49AB-94CA-4A31DB4C9157Q36746688-980CD15E-1964-4499-A61E-9D0B38A7DCEDQ36910062-2E26E7A1-D8FC-4A14-8BDA-EE3F6CF39764Q36954190-313EA182-6599-4F70-80F3-4F228929001FQ37037784-E839855C-2309-44E2-961D-C28D71A0F4D5Q37232663-1303D184-80D9-4B7C-98E0-0A58F16CACC8Q37273887-13880974-67AE-4811-841A-6AA85E8FD7DDQ37295465-6FFDED51-121F-4875-A18A-63E58FA45B63Q37520184-622ACE74-9F18-4FA3-9B2C-94017FE521ACQ38115251-3CC6E9CD-7D5D-47E1-8451-43196F670821Q38367417-AC64B661-4E99-46D4-9CF1-81A99723AF7AQ38904808-917345A4-4B19-4E32-975C-8C449B78FBAAQ39053619-B31D9524-4595-4FD1-8F69-4FE490398BBFQ39362645-02B533C6-B2C3-4A96-843B-A7D4C7552857Q39367312-8BB97D06-9BE3-4C4E-9652-9452693AAE55Q39384187-1C50BEF4-6E0A-4BD0-B2D0-16E5BAA75B4CQ44285666-87B4E3CD-D7C1-41E3-AE1B-9590764F7E70Q47130831-40498D6E-B9AA-4563-9E77-35F08A76DC45Q47140260-DAED4D6D-2A18-4C76-96EB-DCE34B354D5BQ53701146-EDC8036D-C008-4FC2-BC1E-9866F27FE7BD
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genomic profiling of tumor initiating prostatospheres.
@ast
Genomic profiling of tumor initiating prostatospheres.
@en
Genomic profiling of tumor initiating prostatospheres.
@nl
type
label
Genomic profiling of tumor initiating prostatospheres.
@ast
Genomic profiling of tumor initiating prostatospheres.
@en
Genomic profiling of tumor initiating prostatospheres.
@nl
prefLabel
Genomic profiling of tumor initiating prostatospheres.
@ast
Genomic profiling of tumor initiating prostatospheres.
@en
Genomic profiling of tumor initiating prostatospheres.
@nl
P2093
P2860
P356
P1433
P1476
Genomic profiling of tumor initiating prostatospheres.
@en
P2093
Elaine M Hurt
Maria Ana Duhagon
William L Farrar
Xiaohu Zhang
P2860
P2888
P356
10.1186/1471-2164-11-324
P407
P577
2010-05-25T00:00:00Z
P5875
P6179
1015301534